Feasibility and Safety of Walking Football in Patients With Type 2 Diabetes

August 20, 2019 updated by: Romeu Mendes, Universidade do Porto
Our main challenge is to develop a novel physical activity intervention to promote exercise participation sustainability and effective health benefits in type 2 diabetes (T2D) population with minimum health risks. The relevance of this study is supported by four cornerstones: 1) The Portuguese love football and there seems to be a major potential in the implementation of football practice as part of the prevention and treatment of noncommunicable diseases for the middle-aged and elderly Portuguese population; 2) no studies have assessed the feasibility and safety of a walking football exercise program for middle-age and older patients with T2D; 3) the proposed investigation relies on robust methodology; 4) this intervention can have further sustainability with the enrollment of football clubs and primary health care units.

Study Overview

Status

Completed

Detailed Description

This work will be a quasi-experimental study where we aim to test the feasibility and safety of walking football in patients with T2D. The recruitment of participants will be held in primary health care units by Family Medicine medical doctors. All participants will receive instructions to maintain daily-life routines (lifestyle-related physical activity and dietary pattern), and to continue with usual care (diabetes consultations on primary health care units and pharmacological regimen) along the studies duration. All participants will receive basic sports material (sports bag, T-shirt, and sports shoes). Participants will be organized in two teams of 20 players. Each team will have 60-min walking football exercise sessions three times per week (non-consecutive days), during three months (36 sessions). Different walking football exercise strategies will be developed according to participants' motor skills and tested with dose-escalated intensity for its safety (acute effects on capillary glycaemia, blood pressure, foot impact, exercise-related injuries and adverse events) and enjoyment. Exercise intensity will range between light to vigorous. No submaximal or maximal exercises will be tested. Cumulative short-term effects will also be analyzed along the three months through pre- and post-study evaluations. Exercise sessions will be conducted on a sports hall (indoor court) by a football coach and supervised by an exercise physiologist and a nurse.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Porto, Portugal, 4050-600
        • Instituto de Saúde Pública da Universidade do Porto

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • diagnosis of type 2 diabetes for at least 12 months;
  • glycated hemoglobin bellow 10 %;
  • not having started insulin therapy in the previous six months;
  • not having started therapy with sulfonylureas in the previous six months;
  • major complications of diabetes screened and controlled (diabetic retinopathy, diabetic nephropathy and diabetic foot);
  • no symptoms of coronary artery disease;
  • no cardiovascular, respiratory and musculoskeletal contraindications to exercise;
  • not under cancer treatment (radiotherapy or intravenous chemotherapy);
  • without limitations in gait or balance;
  • independent living in the community;
  • not engaged in supervised exercise;
  • non-smokers at least for 6 months.

Exclusion Criteria:

  • cardiological stress test with cardiac or hemodynamic problems

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercise
Walking football exercise program
Participants will be organized in two teams of 20 players. Each team will have 60-min walking football exercise sessions three times per week (non-consecutive days), during three months (36 sessions). Different walking football exercise strategies will be developed according to participants' motor skills and tested with dose-escalated intensity for its safety and enjoyment. Exercise intensity will range between light to vigorous. No submaximal or maximal exercises will be tested. Exercise sessions will be conducted on a sports hall (indoor court) by a football coach and supervised by an exercise physiologist and a nurse.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Exercise intensity - subjective internal load
Time Frame: Through 3 months
OMNI rating of perceived exertion scale during exercise (0 [lowest] to 10 [highest] points)
Through 3 months
Exercise intensity - objective internal load
Time Frame: Through 3 months
Heart rate during exercise
Through 3 months
Exercise intensity - external load
Time Frame: Through 3 months
Distance (km) assessed using GPS tracking during exercise
Through 3 months
Acute glycemic effect
Time Frame: Change between before and immediately after each exercise session
Acute change in capillary blood glucose with exercise sessions
Change between before and immediately after each exercise session
Acute systolic blood pressure effect
Time Frame: Change between before and immediately after each exercise session
Acute change in systolic blood pressure with exercise sessions
Change between before and immediately after each exercise session
Acute diastolic blood pressure effect
Time Frame: Change between before and immediately after each exercise session
Acute change in diastolic blood pressure with exercise sessions
Change between before and immediately after each exercise session
Incidence of falls
Time Frame: Through 3 months
Number of falls during the exercise program
Through 3 months
Incidence of foot injuries
Time Frame: Through 3 months
Number of reported foot injuries during the exercise program
Through 3 months
Incidence of musculoskeletal injuries
Time Frame: Through 3 months
Number of reported musculoskeletal injuries during the exercise program
Through 3 months
Rate of Enjoyment
Time Frame: Through 3 months
Self-reported exercise sessions' enjoyment on a likert scale (1 [lowest] to 5 [highest] points)
Through 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Glycemic control
Time Frame: Change from baseline to 3 months
Glycated hemoglobin (venous blood analysis)
Change from baseline to 3 months
Blood lipid profile
Time Frame: Change from baseline to 3 months
Total cholesterol (venous blood analysis)
Change from baseline to 3 months
Clinical systolic blood pressure
Time Frame: Change from baseline to 3 months
Resting systolic blood pressure
Change from baseline to 3 months
Clinical diastolic blood pressure
Time Frame: Change from baseline to 3 months
Resting diastolic blood pressure
Change from baseline to 3 months
Body mass index
Time Frame: Change from baseline to 3 months
Body mass index
Change from baseline to 3 months
Waist circumference
Time Frame: Change from baseline to 3 months
Waist circumference
Change from baseline to 3 months
Body fat
Time Frame: Change from baseline to 3 months
Body fat (bioelectrical impedance analysis)
Change from baseline to 3 months
Body lean mass
Time Frame: Change from baseline to 3 months
Body lean mass (bioelectrical impedance analysis)
Change from baseline to 3 months
Agility/balance
Time Frame: Change from baseline to 3 months
Timed Up and Go Test
Change from baseline to 3 months
Habitual physical activity
Time Frame: Change from baseline to 3 months
Global Physical Activity Questionnaire
Change from baseline to 3 months
Food pattern
Time Frame: Change from baseline to 3 months
24h-food recall analysis
Change from baseline to 3 months
Cognitive state
Time Frame: Change from baseline to 3 months
Montreal Cognitive Assessment score (0 [lowest] to 30 [highest] points)
Change from baseline to 3 months
Health-related quality of life
Time Frame: Change from baseline to 3 months
EQ-5D-5L questionnaire score (0 [lowest] to 100 [highest] points)
Change from baseline to 3 months
Medication
Time Frame: Change from baseline to 3 months
Number of medications
Change from baseline to 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Romeu Mendes, MD, PhD, EPIUnit - Instituto de Saúde Pública, Universidade do Porto

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • Barbosa A, Brito J, Costa J, Ramos E, Firmino-Machado J, Seabra A, Figueiredo P, Sá MJ, Lunet N, Mendes R. SWEET-FOOTBALL: Development of an evidence-based walking football program for middle-aged and older patients with type 2 diabetes. Football is Medicine Conference 2019 - Programme and Abstracts. Odense: University of Southern Denmark; 2019. p. 32.
  • Barbosa A, Brito J, Sá MJ, Puga F, Firmino-Machado J, Seabra A, Figueiredo P, Ramos E, Lunet N, Mendes R. Adherence and enjoyment of a walking-football program for patients with type 2 diabetes: SWEET-FOOTBALL Project. In: Bunc V, Tsolakidis E, editors. Book of Abstracts of the 24th Annual Congress of the European College of Sport Science. Prague: ECSS; 2019. p. 120-1.
  • Rago V, Brito J, Costa J, Barbosa A, Figueiredo P, Seabra A, Travassos B, Mendes R. Activity profile during walking football training sessions in patients with type 2 diabetes. Football is Medicine Conference 2019 - Programme and Abstracts. Odense: University of Southern University; 2019. p. 41.
  • Costa J, Brito J, Barbosa A, Figueiredo P, Seabra A, Sá MJ, Firmino-Machado J, Ramos E, Mendes R. Nocturnal cardiac autonomic activity in patients with type 2 diabetes engaged in a walking football programme. Football is Medicine Conference 2019 - Programme and Abstracts. Odense: University of Southern Denmark; 2019. p. 39.
  • Barbosa A, Brito J, Costa J, Figueiredo P, Seabra A, Mendes R. Feasibility and safety of a walking football program in middle-aged and older men with type 2 diabetes. Prog Cardiovasc Dis. 2020 Nov-Dec;63(6):786-791. doi: 10.1016/j.pcad.2020.06.014. Epub 2020 Jul 4.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 17, 2018

Primary Completion (Actual)

January 31, 2019

Study Completion (Actual)

June 30, 2019

Study Registration Dates

First Submitted

January 10, 2019

First Submitted That Met QC Criteria

January 16, 2019

First Posted (Actual)

January 22, 2019

Study Record Updates

Last Update Posted (Actual)

August 22, 2019

Last Update Submitted That Met QC Criteria

August 20, 2019

Last Verified

August 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes Mellitus, Type 2

Clinical Trials on Walking football exercise program

3
Subscribe